Cite
MLA Citation
Jonathan W. Goldman et al.. “Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study.” Lung cancer, vol. 149, 2020, pp. 46–52. http://access.bl.uk/ark:/81055/vdc_100113058739.0x00004b